Northwestern Mutual Wealth Management CO Tg Therapeutics, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $101 Billion
- Q2 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 19,300 shares of TGTX stock, worth $450,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,300
Previous 19,300
-0.0%
Holding current value
$450,268
Previous $293,000
17.06%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$319 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$266 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$156 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$85.1 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$75.7 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.39B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...